Nature of business1 |
Country of incorporation |
Percentage holding | |||||
At 31 December | Note | 2022 % |
2021 % |
||||
Unlisted | |||||||
Associates | |||||||
SIOC3 | M | RSA | 20.62 | 20.62 | |||
RBCT | T | RSA | 10.26 | 10.26 | |||
Black Mountain4 | M | RSA | 26.00 | 26.00 | |||
Insect Technology5 | 8.4 | WC | UK | 25.85 | 25.85 | ||
LightApp6 | EN | Israel | 28.01 | 28.59 | |||
GAM7 | EN | RSA | 22.00 | 22.00 | |||
Joint ventures | |||||||
Mafube | M | RSA | 50.00 | 50.00 | |||
Total investments in associates and JVs | 9.5 | ||||||
Unincorporated joint operations | |||||||
Moranbah coal project | M | AUS | 50.00 | 50.00 |
Group | Company | Fair value2 | ||||||
At 31 December | 2022 Rm |
2021 Rm |
2022 Rm |
2021 Rm |
2022 Rm |
2021 Rm |
||
Unlisted | ||||||||
Associates | 15 061 | 15 542 | 143 | |||||
SIOC3 | 11 104 | 12 037 | 34 272 | 32 030 | ||||
RBCT | 2 024 | 2 034 | ||||||
Black Mountain4 | 1 933 | 1 350 | ||||||
Insect Technology5 | 121 | 143 | ||||||
LightApp6 | ||||||||
GAM7 | ||||||||
Joint ventures | 2 999 | 1 780 | ||||||
Mafube | 2 999 | 1 780 | ||||||
Total investments in associates and JVs | 18 060 | 17 322 | 143 | |||||
Unincorporated joint operation | ||||||||
Moranbah coal project |
1 | M — Mining, T — Export terminal, WC — Waste conversion, EN — Energy. |
2 | Fair value represents the directors’ valuation at the reporting date. |
3 | The fair value of SIOC is determined by applying an adjusted equity valuation technique, based on the share price of KIO on 31 December 2022 of R492.30 per share (31 December 2021: R460.09 per share), adjusted for a liquidity discount rate of 20% (2021: 20%). The fair value of SIOC represents a Level 2 valuation, in terms of the fair value hierarchy. |
4 | Black Mountain’s financial year end is 31 March and therefore not co-terminous with that of Exxaro. Financial information has been obtained from published information or management accounts as appropriate. |
5 | The investment in Insect Technology was fully impaired in 2020. |
6 | The investment in LightApp was fully impaired in 2022. |
7 | The investment in GAM was fully impaired in 2019. |
There are no significant restrictions on the ability of associates or joint ventures to transfer funds to Exxaro in the form of cash dividends.
Refer note 10.1.4 for details with regard to capital commitments relating to associates and JVs.
Refer note 16.3.4 for details with regard to loan commitments relating to associates and JVs.
Refer note 13.4 for details with regard to contingent liabilities relating to associates and JVs.